Tuesday, December 14, 2010

CMX157 has highly potent antiviral activity against XMRV

"CMX157 was observed to have highly potent antiviral activity against XMRV in vitro, with an EC50 approximately 20-fold more potent than the anti-retroviral drug azidothymidine (AZT) and 800-fold more potent than tenofovir".

Read more>>

1 comment:

Anonymous said...

I really like your blog and i really appreciate the excellent quality content you are posting here for free for your online readers. thanks peace dale tuck

LinkWithin

Related Posts with Thumbnails